Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in

Cough, Cold and Allergy (Hay Fever) Remedies in Kazakhstan

Nov 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

2020 IMPACT

Cough, cold and allergy (hay fever) remedies looks promising as sales are boosted by COVID-19 pandemic

Cough, cold and allergy (hay fever) remedies is expected to exhibit particularly strong growth in 2020. This strong growth is due to the fact that many of the most common symptoms of COVID-19 are similar to those of seasonal colds.

Brand awareness behind success of Theraflu and Antigrippin as Tailoflen sees a spike in growth

Theraflu and Antigrippin will continue to benefit from particularly strong brand awareness in 2020 and so will account for significant value shares. These brands in particular enjoy a high level of customer loyalty, are readily available, and perceived as being highly effective products.

Munatoril and Gedelix benefit from promotional presence in e-commerce and store-based retailing as consumers increasingly turn to online sales

The brands Munatoril and Gedelix will benefit from an increased visibility in e-commerce and store-based retailing as well as in television advertising in 2020. Whilst neither of these brands are expected to record significant value shares in 2020, their campaigns will make their mark in the category.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Cough, Cold and Allergy Sample Report Cough, Cold and Allergy Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Kazakhstan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Kazakhstan, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Kazakhstan market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Kazakhstan?
What are the major brands in Kazakhstan?
What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Cough, Cold and Allergy (Hay Fever) Remedies in Kazakhstan - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Cough, cold and allergy (hay fever) remedies looks promising as sales are boosted by COVID-19 pandemic

Brand awareness behind success of Theraflu and Antigrippin as Tailoflen sees a spike in growth

Munatoril and Gedelix benefit from promotional presence in e-commerce and store-based retailing as consumers increasingly turn to online sales

RECOVERY AND OPPORTUNITIES

Trend for self-medication to boost the category as seasonal colds remain common in Kazakhstan

The likelihood of Rx to OTC switches raises the prospect of strong forecast period growth

Category will remain under pressure from preventative medicines

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025

Consumer Health in Kazakhstan - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Distribution of Consumer Health by Format: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format and Category: % Value 2020
Table 15 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

Megatrends

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in Kazakhstan

New Report Guarantee

Executive Summary

New Report Guarantee

2020 IMPACT

Cough, cold and allergy (hay fever) remedies looks promising as sales are boosted by COVID-19 pandemic

Brand awareness behind success of Theraflu and Antigrippin as Tailoflen sees a spike in growth

Munatoril and Gedelix benefit from promotional presence in e-commerce and store-based retailing as consumers increasingly turn to online sales

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in Kazakhstan - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Cough, cold and allergy (hay fever) remedies looks promising as sales are boosted by COVID-19 pandemic

Brand awareness behind success of Theraflu and Antigrippin as Tailoflen sees a spike in growth

Munatoril and Gedelix benefit from promotional presence in e-commerce and store-based retailing as consumers increasingly turn to online sales

RECOVERY AND OPPORTUNITIES

Trend for self-medication to boost the category as seasonal colds remain common in Kazakhstan

The likelihood of Rx to OTC switches raises the prospect of strong forecast period growth

Category will remain under pressure from preventative medicines

CATEGORY DATA

Consumer Health in Kazakhstan - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports